If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Year End Update and Board Change

13 Dec 2017 07:00

RNS Number : 1571Z
IDOX PLC
13 December 2017
 

Idox plc

("Idox", the "Company" or the "Group")

Year End Update and Board Change

Idox plc (AIM: IDOX), a leading supplier of specialist information management solutions and services, today provides a further update on results for its financial year ended 31 October 2017 (further to the announcement dated 14 November 2017).

Following internal review in preparation for the full year audit, the Company has identified a small number of revenue items that it does not consider should be recognised in the FY2017 results, which are expected to reduce EBITDA for FY2017 to approximately £20m (compared to about £23m stated in the announcement of 14 November, and £21.5m in 2016). These matters were identified internally and have been brought to the attention of Idox's auditors by the Company.

Clarification of these issues has been complicated by the sudden absence of Andrew Riley, Idox's CEO, due to illness. Richard Kellett-Clarke, currently a non-Executive Director and former CEO of Idox, has agreed to stand in as Interim CEO pending Andrew's return from sick leave.

 

Final Results

As a result of the matters above, the Board expects that the Company's final results for the 2017 financial year will be announced in February 2018.

This announcement is released by Idox plc and contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("MAR"), encompassing information relating to the update and board change described herein, and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of the Company by Jane Mackie, Director.

 

 

Enquiries:

Idox plc +44 (0) 870 333 7101

Laurence Vaughan, Non-Executive Chairman

Richard Kellett-Clarke, Interim Chief Executive

Jane Mackie, Chief Financial Officer

 

N+1 Singer (NOMAD and Broker) +44 (0) 20 7496 3000

Shaun Dobson

Liz Yong

 

MHP (Financial PR) +44 (0) 20 3128 8100

Reg Hoare

Andrew Leach

Charlie Barker

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDTTBTTMBABTJR
Date   Source Headline
10th Apr 202612:11 pmBUSForm 8.3 - [IDOX PLC - 09 04 2026] - (CGWL)
10th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
10th Apr 202611:56 amRNSForm 8.3 - Idox plc Late Notification
10th Apr 202611:42 amRNSForm 8.3 - Idox plc
10th Apr 202611:30 amRNSForm 8.3 - IDOX PLC
9th Apr 20262:18 pmBUSForm 8.3 - [IDOX PLC - 08 04 2026] - (CGWL)
9th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
8th Apr 20261:04 pmRNSForm 8.3 - IDOX PLC
8th Apr 202612:50 pmBUSForm 8.3 - [IDOX PLC - 07 04 2026] - (CGWL)
8th Apr 202612:26 pmRNSForm 8.3 - Idox plc
8th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
8th Apr 20267:00 amRNSUpdate on Letters of Intent
7th Apr 20261:45 pmBUSForm 8.3 - [IDOX PLC - 02 04 2026] - (CGWL)
7th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
2nd Apr 202611:39 amBUSForm 8.3 - [IDOX PLC - 01 04 2026] - (CGWL)
1st Apr 20263:15 pmRNSForm 8.3 - Idox plc
1st Apr 20261:21 pmRNSForm 8.3 - IDOX PLC
1st Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
1st Apr 202611:00 amRNSForm 8.3 IDOX PLC
1st Apr 202610:30 amRNSUpdate on Letters of Intent
1st Apr 20267:00 amRNSUpdate on Letters of Intent
31st Mar 20263:30 pmRNSResult of AGM
31st Mar 20263:27 pmRNSForm 8.3 IDOX PLC
31st Mar 20263:25 pmRNSForm 8.3 - Idox plc
31st Mar 20263:10 pmRNSForm 8.3 IDOX PLC
31st Mar 20263:01 pmRNSForm 8.3 - Idox plc
31st Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
31st Mar 202610:51 amBUSForm 8.3 - [IDOX PLC - 30 03 2026] - (CGWL)
31st Mar 20267:00 amRNSUpdate on Letters of Intent
30th Mar 20263:25 pmRNSForm 8.3 - Idox plc
30th Mar 20263:10 pmRNSForm 8.3 IDOX PLC
30th Mar 20261:16 pmRNSForm 8.3 - Idox plc
30th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
30th Mar 202610:41 amBUSForm 8.3 - [IDOX PLC - 27 03 2026] - (CGWL)
27th Mar 20262:55 pmRNSForm 8.3 - Idox plc
27th Mar 20261:15 pmRNSForm 8.3 - IDOX PLC
27th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
27th Mar 202610:44 amBUSForm 8.3 - [IDOX PLC - 26 03 2026] - (CGWL)
27th Mar 20267:00 amRNSUpdate on Letters of Intent
26th Mar 20263:27 pmRNSForm 8.3 - IDOX PLC
26th Mar 20263:25 pmRNSForm 8.3 - Idox plc
26th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
26th Mar 20269:29 amBUSForm 8.3 - [IDOX PLC - 24 03 2026] - (CGWL)
26th Mar 20267:00 amRNSUpdate on Letters of Intent
25th Mar 20264:19 pmRNSUpdate Regarding Regulatory Conditions
25th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
25th Mar 20269:58 amBUSForm 8.3 - [IDOX PLC - 24 03 2026] - (CGWL)
25th Mar 20267:00 amRNSUpdate on Letters of Intent
24th Mar 20263:25 pmRNSForm 8.3 - Idox plc
24th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.